Researchers acknowledged improvements in patients’ anxiety, sleep quality, social effects, and behavior.
The post Systematic Review: Cannabis Extracts Safe and Effective in Pediatric Patients With Autism appeared first on NORML.
Category: The Business of Cannabis
-
Systematic Review: Cannabis Extracts Safe and Effective in Pediatric Patients With Autism
-
Federal: President Trump Taps Former Fox News Reporter for Drug Czar Position
The Drug Czar’s office oversees an estimated $44 billion in federal spending.The post Federal: President Trump Taps Former Fox News Reporter for Drug Czar Position appeared first on NORML.
-
Delota continues on path to profitability with positive fourth-quarter results
Delota Corp. (CSE: NIC) reported year-over-year revenue growth of 18% for the 12-month period that ended Jan. 31, primarily driven by direct-to-consumer sales through its 180 Smoke stores and online platform.
The company announced in January that it was shifting the end of its fiscal year to March 31 from Jan….
Please login to read all 373 words.
-
Cannabis signals from Trump growing increasingly murky
Cannabis industry insiders may have grown weary of peering into their crystal balls to determine whether federal reform of any kind is on the horizon during the new Trump administration, but it doesn’t appear that the murkiness will lift anytime soon.
That’s in spite of the president nominating a cannabis champion…
Please login to read all 648 words.
-
New Hampshire Senate committee kills marijuana bills, including rec legalization
A New Hampshire state Senate committee dealt a likely death blow to a trio of pro-marijuana bills, voting down each of them during a hearing this week, although technically each measure could still pass the full Senate when they’re delivered to the chamber floor later in the legislative session.
According to…
Please login to read all 262 words.
-
Illinois sales fall again in February
Illinois marijuana sales took a 7% month-over-month dip in February, falling to $150.3 million from January’s tally of $161.7 million, according to statistics from the state Cannabis Regulation Oversight Officer.
Recreational sales – the lion’s share of the market – pulled in $130.6 million for the month, down from $140.2 million…
Please login to read all 232 words.
-
HOPE Therapeutics to buy clinic company Dura Medical
HOPE Therapeutics, an interventional psychiatry network wholly owned by NRx Pharmaceuticals (Nasdaq: NRXP), today announced it was buying Dura Medical per the previously announced non-binding letter of intent.
Financial terms of the transaction were not disclosed. Dura Medical Founder Stephen Durand will be named director of Florida clinic operations.
Hope stressed that Dura…
Please login to read all 348 words.
-
Pennsylvania’s medical market fears a state-store model for adult-use
It’s no secret that Pennsylvania Gov. Josh Shapiro wants his state to legalize adult-use cannabis, after the medical marijuana industry has already put up big sales numbers. The state reported $1.7 billion in MMJ sales for 2024 and $7 billion since the program was initiated in 2020, according to the…
Please login to read all 638 words.
-
Enveric posts $9.5M loss for 2024, but revenue could be on horizon with licensing deals
Florida-based psychedelics firm Enveric Biosciences (NASDAQ: ENVB), which is still in the pre-revenue stage, this week reported a $9.5 million net loss for 2024, down from the $17.4 million it lost in 2023 but still well in the red as it continues developing non-hallucinatory treatments for mental health disorders.
The yearly…
Please login to read all 356 words.
-
CanadaBis Capital posts sales growth ahead of Simply Solventless deal
CanadaBis Capital Inc. (TSXV: CANN) reported revenue of C$4.9 million for its second quarter of its fiscal 2025, up from C$4.3 million versus the same period last year, but the company saw a slight decline in net income for the period.
The cannabis producer and processor posted net income of C$96,917…
Please login to read all 480 words.